Status:
WITHDRAWN
Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203
Lead Sponsor:
NVP Healthcare
Conditions:
Healthy
Eligibility:
MALE
19-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.
Detailed Description
aceclofenac and eperisone(low back pain)
Eligibility Criteria
Inclusion
- Healthy male volunteers, age between 19 and 45
- BMI of \>19kg/m2 and \<28kg/m2 subject
- Informed of the investigational nature of this study and voluntarily agree to participate in this study
Exclusion
- Use of any prescription medication within 14 days prior to Day 1
- Use of any medication within 7 days prior to Day 1
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02289274
Start Date
November 1 2019
End Date
December 1 2019
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navipharm
Suwon, Gyeonggi-do, South Korea, 16209